Ron Cohen | Chief Executive Officer |
Lauren Sabella | Chief Commercial Officer |
David Lawrence | CTO, Chief of Business Operations & Principal Accounting Officer |
Felicia Vonella | Vice President of Investor Relations |
Salveen Richter | Goldman Sachs |
Nate Tower | Stifel |
Neena Altaf | JPMorgan |
Michael Yee | Jefferies |
Kenneth Atkins | Cowen |
Welcome to the Acorda Therapeutics, Third Quarter 2019 Updates. At this time all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company’s request.
I will now introduce your host for today's call, Felicia Vonella, Vice President of Investor Relations at Acorda.